Despite the limitations of cell line experiments, an Italian study found that VEGF may play a significant role in the proliferative effects of estrogens on human cholangiocarcinoma, and strategies based on ER and/or VEGF antagonism could aid in the delay of cancer progression [43]. The gene discussed is VEGFA; the disease is cholangiocarcinoma.